Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol
CONCLUSION: Given the importance of this drug in the management of hyperthyroidism, MMI should not be withdrawn in cases of urticaria. After the resolution of urticaria, a gradual reintroduction of MMI should be attempted with concomitant antihistamine therapy.PMID:38403562 | DOI:10.1016/j.therap.2023.12.006 (Source: Therapie)
Source: Therapie - February 25, 2024 Category: Psychiatry & Psychology Authors: Ferdaous Chahed Nadia Ben Fredj Haifa Ben Romdhane Zohra Chadli Amel Chaabane Najah Ben Fadhel Karim Aouam Source Type: research

Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol
CONCLUSION: Given the importance of this drug in the management of hyperthyroidism, MMI should not be withdrawn in cases of urticaria. After the resolution of urticaria, a gradual reintroduction of MMI should be attempted with concomitant antihistamine therapy.PMID:38403562 | DOI:10.1016/j.therap.2023.12.006 (Source: Therapie)
Source: Therapie - February 25, 2024 Category: Psychiatry & Psychology Authors: Ferdaous Chahed Nadia Ben Fredj Haifa Ben Romdhane Zohra Chadli Amel Chaabane Najah Ben Fadhel Karim Aouam Source Type: research

Cannabidiol (CBD): Confronting consumers' expectations of therapeutic benefits with pharmacological reality
Therapie. 2024 Feb 7:S0040-5957(24)00027-1. doi: 10.1016/j.therap.2024.01.006. Online ahead of print.ABSTRACTIn recent years, the increase in cannabidiol (CBD) sales in Europe has raised questions regarding the legal status of this product, as well as its safety of use. Consumers seem to be looking for solutions to various health issues. However, the scientific reality is much more nuanced. The European CBD market emerged in Switzerland in 2016 and subsequently expanded across the continent. This expansion has been facilitated by the establishment of delta-9-tetrahydrocannabinol (THC) concentration limits for these product...
Source: Therapie - February 21, 2024 Category: Psychiatry & Psychology Authors: Bruno Revol Julie Bagnolati Jo ëlle Micallef Emilie Jouanjus Source Type: research

Cannabidiol (CBD): Confronting consumers' expectations of therapeutic benefits with pharmacological reality
Therapie. 2024 Feb 7:S0040-5957(24)00027-1. doi: 10.1016/j.therap.2024.01.006. Online ahead of print.ABSTRACTIn recent years, the increase in cannabidiol (CBD) sales in Europe has raised questions regarding the legal status of this product, as well as its safety of use. Consumers seem to be looking for solutions to various health issues. However, the scientific reality is much more nuanced. The European CBD market emerged in Switzerland in 2016 and subsequently expanded across the continent. This expansion has been facilitated by the establishment of delta-9-tetrahydrocannabinol (THC) concentration limits for these product...
Source: Therapie - February 21, 2024 Category: Psychiatry & Psychology Authors: Bruno Revol Julie Bagnolati Jo ëlle Micallef Emilie Jouanjus Source Type: research

Cannabidiol (CBD): Confronting consumers' expectations of therapeutic benefits with pharmacological reality
Therapie. 2024 Feb 7:S0040-5957(24)00027-1. doi: 10.1016/j.therap.2024.01.006. Online ahead of print.ABSTRACTIn recent years, the increase in cannabidiol (CBD) sales in Europe has raised questions regarding the legal status of this product, as well as its safety of use. Consumers seem to be looking for solutions to various health issues. However, the scientific reality is much more nuanced. The European CBD market emerged in Switzerland in 2016 and subsequently expanded across the continent. This expansion has been facilitated by the establishment of delta-9-tetrahydrocannabinol (THC) concentration limits for these product...
Source: Therapie - February 21, 2024 Category: Psychiatry & Psychology Authors: Bruno Revol Julie Bagnolati Jo ëlle Micallef Emilie Jouanjus Source Type: research

Cannabidiol (CBD): Confronting consumers' expectations of therapeutic benefits with pharmacological reality
Therapie. 2024 Feb 7:S0040-5957(24)00027-1. doi: 10.1016/j.therap.2024.01.006. Online ahead of print.ABSTRACTIn recent years, the increase in cannabidiol (CBD) sales in Europe has raised questions regarding the legal status of this product, as well as its safety of use. Consumers seem to be looking for solutions to various health issues. However, the scientific reality is much more nuanced. The European CBD market emerged in Switzerland in 2016 and subsequently expanded across the continent. This expansion has been facilitated by the establishment of delta-9-tetrahydrocannabinol (THC) concentration limits for these product...
Source: Therapie - February 21, 2024 Category: Psychiatry & Psychology Authors: Bruno Revol Julie Bagnolati Jo ëlle Micallef Emilie Jouanjus Source Type: research

Ipomoea species, glorious but dangerous plants: A case-series
Therapie. 2024 Feb 2:S0040-5957(24)00009-X. doi: 10.1016/j.therap.2024.01.005. Online ahead of print.NO ABSTRACTPMID:38369406 | DOI:10.1016/j.therap.2024.01.005 (Source: Therapie)
Source: Therapie - February 18, 2024 Category: Psychiatry & Psychology Authors: Louise Huleux Emilie Lefebvre Ramy Azzouz Lauriane Charuel Anne-Sylvie Caous Sylvie Deheul Caroline Victorri-Vigneau Reynald Le Boisselier R égis Bordet Sandra Thorign é Louise Carton Source Type: research

Ipomoea species, glorious but dangerous plants: A case-series
Therapie. 2024 Feb 2:S0040-5957(24)00009-X. doi: 10.1016/j.therap.2024.01.005. Online ahead of print.NO ABSTRACTPMID:38369406 | DOI:10.1016/j.therap.2024.01.005 (Source: Therapie)
Source: Therapie - February 18, 2024 Category: Psychiatry & Psychology Authors: Louise Huleux Emilie Lefebvre Ramy Azzouz Lauriane Charuel Anne-Sylvie Caous Sylvie Deheul Caroline Victorri-Vigneau Reynald Le Boisselier R égis Bordet Sandra Thorign é Louise Carton Source Type: research

Ipomoea species, glorious but dangerous plants: A case-series
Therapie. 2024 Feb 2:S0040-5957(24)00009-X. doi: 10.1016/j.therap.2024.01.005. Online ahead of print.NO ABSTRACTPMID:38369406 | DOI:10.1016/j.therap.2024.01.005 (Source: Therapie)
Source: Therapie - February 18, 2024 Category: Psychiatry & Psychology Authors: Louise Huleux Emilie Lefebvre Ramy Azzouz Lauriane Charuel Anne-Sylvie Caous Sylvie Deheul Caroline Victorri-Vigneau Reynald Le Boisselier R égis Bordet Sandra Thorign é Louise Carton Source Type: research

Questionnaire about therapeutic drug monitoring (TDM) of psychotropics for a panel of French psychiatrists
Therapie. 2024 Feb 1:S0040-5957(24)00008-8. doi: 10.1016/j.therap.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38355346 | DOI:10.1016/j.therap.2024.01.004 (Source: Therapie)
Source: Therapie - February 14, 2024 Category: Psychiatry & Psychology Authors: Sylvain Couderc Zoubir Djerada Florence Rivals Anne-Sophie Lemaire-Hurtel V éronique Lelong-Boulouard B énédicte Lelièvre Chadi Abbara Claire Lafay Emuri Abe Fr édéric Libert Claire Pressiat Damien Montange Laurent Imbert Julia Tonini Marie Lenski R Source Type: research

Questionnaire about therapeutic drug monitoring (TDM) of psychotropics for a panel of French psychiatrists
Therapie. 2024 Feb 1:S0040-5957(24)00008-8. doi: 10.1016/j.therap.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38355346 | DOI:10.1016/j.therap.2024.01.004 (Source: Therapie)
Source: Therapie - February 14, 2024 Category: Psychiatry & Psychology Authors: Sylvain Couderc Zoubir Djerada Florence Rivals Anne-Sophie Lemaire-Hurtel V éronique Lelong-Boulouard B énédicte Lelièvre Chadi Abbara Claire Lafay Emuri Abe Fr édéric Libert Claire Pressiat Damien Montange Laurent Imbert Julia Tonini Marie Lenski R Source Type: research

Questionnaire about therapeutic drug monitoring (TDM) of psychotropics for a panel of French psychiatrists
Therapie. 2024 Feb 1:S0040-5957(24)00008-8. doi: 10.1016/j.therap.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38355346 | DOI:10.1016/j.therap.2024.01.004 (Source: Therapie)
Source: Therapie - February 14, 2024 Category: Psychiatry & Psychology Authors: Sylvain Couderc Zoubir Djerada Florence Rivals Anne-Sophie Lemaire-Hurtel V éronique Lelong-Boulouard B énédicte Lelièvre Chadi Abbara Claire Lafay Emuri Abe Fr édéric Libert Claire Pressiat Damien Montange Laurent Imbert Julia Tonini Marie Lenski R Source Type: research

Questionnaire about therapeutic drug monitoring (TDM) of psychotropics for a panel of French psychiatrists
Therapie. 2024 Feb 1:S0040-5957(24)00008-8. doi: 10.1016/j.therap.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38355346 | DOI:10.1016/j.therap.2024.01.004 (Source: Therapie)
Source: Therapie - February 14, 2024 Category: Psychiatry & Psychology Authors: Sylvain Couderc Zoubir Djerada Florence Rivals Anne-Sophie Lemaire-Hurtel V éronique Lelong-Boulouard B énédicte Lelièvre Chadi Abbara Claire Lafay Emuri Abe Fr édéric Libert Claire Pressiat Damien Montange Laurent Imbert Julia Tonini Marie Lenski R Source Type: research

Interest of a short educational intervention coordinated by community pharmacists for elderly type 2 diabetes patients in a rural area
Therapie. 2024 Jan 23:S0040-5957(24)00006-4. doi: 10.1016/j.therap.2024.01.003. Online ahead of print.ABSTRACTThe number of elderly people with type 2 diabetes (T2D) is increasing worldwide. Community pharmacies, thanks to their proximity, provide more easy access to therapeutic education for rural patients. Populations living in isolated areas require specific educational resources related to their condition. The aim of this project was to perform a short (FLASH) educational intervention, coordinated by community pharmacists, and then evaluate the impact of this intervention on patient knowledge of their disease. The stud...
Source: Therapie - February 10, 2024 Category: Psychiatry & Psychology Authors: Edouard Foug ère Jean-Michel Delavaud Claire Filloux Aurore Danigo Catherine Fagn ère J érémy Jost Marie-Pierre Teissier Claire Demiot Source Type: research

Chronic spontaneous urticaria after COVID-19 vaccination
Therapie. 2024 Jan 26:S0040-5957(24)00007-6. doi: 10.1016/j.therap.2023.06.007. Online ahead of print.NO ABSTRACTPMID:38320893 | DOI:10.1016/j.therap.2023.06.007 (Source: Therapie)
Source: Therapie - February 6, 2024 Category: Psychiatry & Psychology Authors: Öner Özdemir Source Type: research